Literature DB >> 22902029

Long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with autosomal dominant polycystic kidney disease.

Mohammed Haseebuddin1, Youssef S Tanagho, Melissa Millar, Timur Roytman, Cathy Chen, Ralph V Clayman, Brent Miller, Alana Desai, Brian Benway, Sam Bhayani, Robert S Figenshau.   

Abstract

PURPOSE: Cyst proliferation in patients with autosomal dominant polycystic kidney disease is associated with renal failure, hypertension and pain. We examined the long-term impact of laparoscopic cyst decortication on renal function, hypertension and pain control in patients with adult dominant polycystic kidney disease presenting with refractory pain.
MATERIALS AND METHODS: Between 1994 and 2003, 37 patients with adult dominant polycystic kidney disease underwent laparoscopic cyst decortication at Barnes-Jewish Hospital. A total of 19 patients (4 male, 15 female) with at least 3-year followup were included in the study. Renal function was evaluated using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) estimated glomerular filtration rate formula. End stage renal disease was defined as progression to transplant, dialysis or stage 5 chronic kidney disease. Hypertension was evaluated using the antihypertensive therapeutic index. Pain assessment was based primarily on a telephone questionnaire.
RESULTS: At a mean followup of 10.9 years (range 6.4 to 16.9), 67% of evaluable patients reported more than 50% improvement in pain. Ten patients had progression to end stage renal disease--3 dialysis, 6 transplant, and 1 chronic kidney disease stage 5. Two patients had stage 5 chronic kidney disease at initial presentation. A comparison of preoperative estimated glomerular filtration rate between patients with and those without end stage renal disease revealed a lower preoperative estimated glomerular filtration rate in the former group (43.4 vs 75.4 ml/minute/1.73 m(2), p = 0.01). Of the patients 53% had an improved or stable antihypertensive therapeutic index at last followup, although no improvement in mean overall antihypertensive therapeutic index was noted (4.7 pre-laparoscopic cyst decortications vs 7.0 post-laparoscopic cyst decortications, p = 0.28).
CONCLUSIONS: Durable pain relief but not hypertension control was seen at 10-year followup. Preoperative estimated glomerular filtration rate is a strong predictor of post-laparoscopic cyst decortication progression to end stage renal disease. A cautious approach with laparoscopic cyst decortication should be taken in patients with poor preoperative renal function.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22902029     DOI: 10.1016/j.juro.2012.06.026

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.

Authors:  Eyüp Veli Küçük; Ahmet Tahra; Ahmet Bindayi; Ferhat Yakup Suçeken; Fikret Fatih Önol; Uğur Boylu
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

2.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

3.  Quest for the Cure: Testing the Old and New to Prevent Progression of Autosomal Dominant Polycystic Kidney Disease.

Authors:  Godela Brosnahan
Journal:  Kidney Med       Date:  2019-10-31

4.  Laparoscopic nephrectomy for polycystic kidney: comparison of the transperitoneal and retroperitoneal approaches.

Authors:  Thibaut Benoit; Benoit Peyronnet; Mathieu Roumiguié; Grégory Verhoest; Jean-Baptiste Beauval; Arnaud Delreux; Dominique Chauveau; Bernard Malavaud; Andréa Manunta; Michel Soulié; Pascal Rischmann; Karim Bensalah; Xavier Gamé
Journal:  World J Urol       Date:  2015-12-10       Impact factor: 4.226

Review 5.  Surgical cyst decortication in autosomal dominant polycystic kidney disease.

Authors:  Melissa Millar; Youssef S Tanagho; Mohammed Haseebuddin; Ralph V Clayman; Sam B Bhayani; R Sherburne Figenshau
Journal:  J Endourol       Date:  2013-02-05       Impact factor: 2.942

Review 6.  A stepwise approach for effective management of chronic pain in autosomal-dominant polycystic kidney disease.

Authors:  Niek F Casteleijn; Folkert W Visser; Joost P H Drenth; Tom J G Gevers; Gerbrand J Groen; Marie C Hogan; Ron T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2014-09       Impact factor: 5.992

Review 7.  New treatment paradigms for ADPKD: moving towards precision medicine.

Authors:  Matthew B Lanktree; Arlene B Chapman
Journal:  Nat Rev Nephrol       Date:  2017-10-09       Impact factor: 28.314

8.  Should kidney volume be used as an indicator of surgical occasion for patients with autosomal dominant polycystic kidney disease?

Authors:  Jiang Yu; Bin Li; Yu-Zhu Xiang; Tai-Guo Qi; Xun-Bo Jin; Hui Xiong
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report.

Authors:  Patrizia Natale; Ronald D Perrone; Allison Tong; Tess Harris; Elyssa Hannan; Angela Ju; Eva Burnette; Niek F Casteleijn; Arlene Chapman; Sarah Eastty; Ron T Gansevoort; Marie Hogan; Shigeo Horie; Bertrand Knebelmann; Richard Lee; Reem A Mustafa; Richard Sandford; Amanda Baumgart; Jonathan C Craig; Gopala K Rangan; Bénédicte Sautenet; Andrea K Viecelli; Noa Amir; Nicole Evangelidis; Chandana Guha; Charlotte Logeman; Karine Manera; Andrea Matus Gonzalez; Martin Howell; Giovanni F M Strippoli; Yeoungjee Cho
Journal:  Clin Kidney J       Date:  2021-07-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.